Ottawa, May 06, 2025 (GLOBE NEWSWIRE) — According to Statifacts, the global eClinical solutions market size surpassed USD 10,730 million in 2024 and is estimated to attain USD 40,500 million by 2034, growing at a CAGR of 14.2% during the forecast period from 2025 to 2034. The eClinical solutions market growth is driven by rising R&D expenditure across the globe, rising adoption of software solutions across the globe, and increasing demand for clinical trials outsourcing.
Request a Sample Databook to Explore our Insights@ https://www.statifacts.com/stats/databook-download/8121
eClinical Solutions Market Overview
eClinical solutions’ industry-leading data and analytics platform and biometrics services experts help biopharma researchers at mid-size, large, and emerging life sciences organizations manage trial complexity with fewer resources and less time. The benefits of eClinical solutions include improving trials from acquisition to submission, quickening cycle times, improving productivity, and bringing out tomorrow’s breakthroughs.
The eClinical solutions market refers to the production, distribution, and use of eClinical solutions, which firstly targets physician practices and allows physicians to view and use as much or as little personal wellness data, with the patient’s consent, as they want. eClinical solutions include electronic data capture (EDC), clinical trial management systems (CDMS), randomization and trial supply management (RTSM), and electronic patient-reported outcomes (ePRO).
Integration of advanced technologies like machine learning (ML), artificial intelligence (AI), and cloud computing in eClinical solutions improves trial management and data processing modeling continually.
- In November 2024, several AI-based Healthcare Innovations were introduced by a leading provider of cloud-based electronic health records (EHR) and practice management solutions, eClinicalWorks.
Recent Private Company Investments in the e-Clinical Solutions Market
| Company | Investment Details | Date/Period |
| eClinical Solutions | Acquired by GI Partners; GI Partners took a majority stake in September 2024. | September 2024 |
| Lokavant | Received $8 million strategic investment from Mitsui & Co. Ltd. to expand in Asia Pacific. | October 2023 |
| Ascertain | Raised $10 million in Series A funding led by Deerfield Management to enhance AI-driven healthcare administration. | May 2025 |
eClinical Solutions Market Key Highlights
- North America dominated the global market with the largest market share in 2024.
- Asia Pacific is projected to expand at the fastest CAGR during the forecast period.
- By product, the clinical trial management system (CTMS) segment captured a significant portion of the eClinical solutions market in 2024.
- By product, the electronic clinical outcome assessment (eCOA) segment is predicted grow at the fastest rate in the market between 2025 and 2034.
- By end use, the Contract Research Organizations (CROs) segment registered the maximum market share in 2024.
- By end use, the pharma & biotech organizations segment is predicted to grow with the fastest CAGR in the market from 2025 to 2034.
- By delivery mode, the web and cloud-based segment accounted the highest market share in 2024.
- By delivery mode, the on-premises segment is observed to grow at a notable rate during the forecast period.
- By development phase, the Phase III segment led the eClinical solutions market.
- By development phase, the Phase I segment is projected to experience the highest growth rate in the market between 2024 to 2034.
Major Key Trends in the eClinical Solutions Market:
- Focus on patient-oriented solutions: eClinical solutions improve data accuracy, efficiency, and patient engagement in decentralized clinical trials for more efficient, faster research that brings hope to those who need it most. As compared to traditional trials, patients need to go to a specific clinical site, eClinical solutions, like virtual tools and technologies, making it easier for patients to participate from the comfort of their homes.
- Rising adoption of telemedicine and remote monitoring: Telemedicine improves self-management, physical activity, and rehabilitation. Telemedicine increases access to continuity and care services for cancer patients, reduces ED times, better medication adherence, and enhances satisfaction scores.
Order the Premium Databook Today at the Discounted Rate of $1550! https://www.statifacts.com/order-databook/8121
Limitations & Challenges in the eClinical Solutions Market:
- Data security and privacy issues: Data security and privacy issues in clinical trials can be caused by many behaviors, including significant carelessness, intentional or unintentional non-compliance, misconduct, and fraud. They can compromise the validity of the study results.
- Lack of awareness of eClinical solutions: Lack of awareness of clinical trials can be a reason for lower patient participation. Lack of awareness can reduce recruitment for cancer clinical trials.
Development of eClinical Solutions Platforms: Market’s Largest Potential
eClinical solutions platforms are a type of randomized clinical trial that enables the simultaneous comparison of many intervention groups against a single control group that acts as a common based on a prespecified interim analysis plan. eClinical solutions platform transforms healthcare management with HMS/HER software, pharmacy management system, and LIMS. eClinical solutions platform built for IVF/fertility, dental, mental health, and medical health clinics.
- In September 2023, the eClinical Platform App in China, ensuring full compliance and accessibility, was launched by a leading global provider of innovative solutions for patient engagement and data collection in clinical trials, Datacubed Health.
eClinical Solutions Market Scope
| Report Attribute | Key Statistics |
| Market Size in 2025 | USD 12,260 Million |
| Market Size by 2034 | USD 40,500 Million |
| Growth Rate from 2025 to 2034 | CAGR of 14.2% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | By Product, By Delivery Mode, By Development Phase, By End-use, and By Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Regional Analysis:
North America held the Dominant position: Technological Advancement to Support Growth
North America dominated the global eClinical solutions market in 2024. Changing lifestyle, rising target population, rising adoption of information on patient health through eClinical solutions, and rising digitalization are driving the growth of the market in North America.
Major Factors for the Market’s Expansion in North America
- In June 2024, a new digital bank for the US healthcare industry, powered by Finastra, was launched by Bank Midwest.
- In April 2025, the launch of the CORE 500 Digital Stethoscope and Eko+ membership in Canada was announced by Eko Health.
Strategic Investments & Acquisitions in North America
- Ascertain: In May 2025, Ascertain, a healthcare startup led by former Amazon executive Dr. Mark Michalski, secured $10 million in Series A funding. The investment was led by Deerfield Management and aims to enhance healthcare administration using AI agents.
- Science 37: In March 2024, Science 37, a company specializing in decentralized clinical trials, was acquired by eMed, LLC. This acquisition enhances eMed’s capabilities in telehealth and diagnostics, expanding its reach in the e-clinical solutions market.
- Syneos Health: In March 2023, Syneos Health signed a multi-year deal to collaborate with Microsoft Research in developing a platform to leverage machine learning for the optimization of clinical trials. This partnership aims to enhance Syneos Health’s capabilities in providing e-clinical solutions.
What Expect from Asian Countries till 2034?
Asia Pacific is projected to host the fastest-growing market in the coming years. Rising R&D spending across the globe, rising software solutions adoption in clinical trials, and increasing government funding in clinical trials are driving the growth of the eClinical solutions market in the Asia Pacific region.
Top Asian Countries for eClinical Solutions
India: In February 2025, the India Digital Health Activator, a new initiative to accelerate digital health adoption, interoperability, and innovation through public-private collaboration, was launched by the World Economic Forum (WEF).
Japan: In February 2025, to revolutionize digital transformation in Japan’s life sciences sector, the global leader in enterprise validation lifecycle management systems (VLMS), ValGenesis Inc., and Hitachi Industry & Control Solutions, Ltd., collaborated.
eClinical Solutions Market Segmentation Insights
Product Insights
The clinical trial management system (CTMS) segment held a dominant presence in the eClinical solutions market in 2024. The benefits of CTMS include access to up-to-date and accurate study information. A CTMS automates and centralizes various trial management functions from planning to study closure. CTMS helps teams ensure regulatory compliance, reduce errors, and enhance collaboration by providing a single source of truth for all trial data.
The electronic clinical outcome assessment (eCOA) segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034. The eCOA application is designed to accurately capture PRO data. It offers a range of customizable assessments and diaries tailored to meet the specific requirements of each clinical trial.
End Use Insights
The Contract Research Organizations (CROs) segment accounted for a considerable share of the eClinical solutions market in 2024. The CRO provides clinical, scientific, and business continuity for clinical trial sponsors. In advancing clinical research, CRO play an important role. They provide a controlled and structured environment to test new drugs, treatments, and other medical devices before being approved for widespread use.
The pharma & biotech organizations segment is projected to experience the highest growth rate in the market between 2024 to 2034. Pharma & biotech organizations have a major role in drug discovery and development for the understanding of many diseases and their new treatment strategies and therapeutic interventions.
Delivery Mode Insights
The web and cloud-based segment led the eClinical solutions market. The benefits of web and cloud-based clinical solutions include reducing the risk of data loss, reducing network equipment & staff costs, increasing patient data accessibility, automating data scalability & processing, and accelerating clinical analyses and care processes.
On-premises segment is set to experience the fastest rate of market growth from 2025 to 2034. On-premises storage can ensure the security and accessibility of sensitive patient data. It offers full control over data, customization options, and improved security.
Development Phase Insights
The Phase III segment registered its dominance over the eClinical solutions market in 2024. Phase III trial collects comprehensive safety data, enabling researchers and regulatory authorities to make informed decisions about the benefits of the drug versus its potential risks.
The Phase I segment is anticipated to grow with the highest CAGR in the market during the studied years. Phase I studies of a new drug are generally the first that involve people. Phase I studies are used to find the highest dose of the new treatment that can be given safely without causing severe side effects.
Browse More Research Reports:
Order the Premium Databook Today at the Discounted Rate of $1550! https://www.statifacts.com/order-databook/8121
eClinical Solutions Market Top Companies:
- Fountayn, formerly known as Datatrak International, Inc.
- Oracle
- Calyx, formerly part of Parexel International Corporation
- Medidata (Dassault Systemes)
- CRF Health (Signant Health)
- Clario (ERT and Bioclinica)
- eClinicalWorks
- Merative (IBM Watson Health)
- Anju Software
- eClinical Solutions
- MaxisIT
- IQVIA
- Castor
- Veeva Systems
Recent Breakthroughs in the Global eClinical Solutions Market:
- In March 2025, the tech-driven Aayu Chemist app and Medcords platform from Medcords Healthcare Solutions were launched by Entero Healthcare.
- In July 2024, the North American launch of the Integrated Solution for Digital Transformation in Pathology was announced by AGFA HealthCare and Corista.
Segments Covered in the Report
By Product
- Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
- Clinical Trial Management Systems (CTMS)
- Clinical Analytics Platforms
- Randomization and Trial Supply Management (RTSM)
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment (eCOA)
- Safety Solutions
- Electronic Trial Master File (eTMF)
- Electronic Consent (eConsent)
By Delivery Mode
- Cloud and Web Based
- On-Premise
By Development Phase
- Phase I
- Phase II
- Phase III
- Phase IV
By End-use
- Hospitals/Healthcare providers
- Contract Research Organizations (CROs)
- Academic Institutes
- Pharma & Biotech Organizations
- Medical Device Manufacturers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
You can place an order or ask any questions, please feel free to contact us at [email protected]
Statifacts offers subscription services for data and analytics insights. This page provides options to explore and purchase a subscription tailored to your needs, granting access to valuable statistical resources and tools. Access here – https://www.statifacts.com/get-a-subscription
Contact US
About US
Statifacts is a leading provider of comprehensive market research and analytics services, offering over 1,000,000 market and custoer data sets across various industries. Their platform enables businesses to make informed strategic decisions by providing full access to statistics, downloadable in formats such as XLS, PDF, and PNG.
Our Trusted Data Partners:
Precedence Research | Towards Healthcare | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Dental | Towards EV Solutions | Nova One Advisor
